A Long-Term Follow-Up Study to Assess the Safety and Efficacy of B-Cell-Directed Therapy in Patients with Systemic Autoimmune Disease (B-CARE)
Autoimmune conditions happen when the body's natural defence system accidentally attacks its own healthy tissues. B cells are a type of white blood cell that play a major role in this process. Some modern treatments work by targeting and calming down these specific cells. This long-term follow-up study, called B-CARE, looks at adults who have had B-cell-directed therapies for an autoimmune disease. Doctors want to monitor participants over an extended period to see how safe these medicines are in the long run and whether they keep symptoms under control. By taking part, people help researchers collect vital health information. This knowledge can show whether any late side effects appear and how long the benefits of treatment last. The findings will help guide doctors in choosing the safest, most effective options for people living with complex autoimmune diseases in the future.
At a glance
What is this study about?
In a healthy body, the immune system acts like a shield, fighting off germs and infections. In systemic autoimmune diseases, this shield turns inward. The immune system mistakenly attacks healthy organs, joints, and tissues, causing long-lasting swelling, pain, and damage throughout the body. White blood cells known as B cells are often deeply involved in these harmful attacks.
To treat these illnesses, doctors sometimes use targeted therapies designed to reduce or change how B cells behave. While earlier trials show that these medicines can be very helpful in calming down disease flares, scientists still need to know what happens years after treatment. The B-CARE study was created to follow patients over the long term to see how they get on.
By tracking participants over time, researchers hope to answer two big questions: does the treatment continue to keep the illness under control, and do any unexpected side effects appear later on? Gathering this real-world, long-term evidence is crucial. It helps healthcare teams give clear, trustworthy advice to patients who may need these powerful therapies in the years ahead.
Key takeaways
- The B-CARE study tracks the long-term safety and success of B-cell therapies in adults.
- It helps doctors understand how well treatments work years after they are given.
- Participation involves routine health check-ups, questionnaires, and blood tests.
- You can take part alongside your normal medical care and leave whenever you like.
- Your involvement helps improve future care for people with autoimmune diseases.
Who may be eligible?
This study is open to adults aged 18 and older who have a diagnosed systemic autoimmune condition. Because this is a follow-up study, it is generally aimed at people who have already received, or are scheduled to receive, a specific treatment that targets B cells as part of their care or through an earlier trial.
Both men and women can join. Your overall health and medical history will be reviewed by the research team to confirm that this long-term monitoring programme is suitable for you.
People who do not have an autoimmune disease, or who have not received the relevant B-cell therapy, will not be eligible to take part. The study team can check your records to confirm if your specific treatment qualifies.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am aged 18 or older.
- I have been diagnosed with a systemic autoimmune disease.
- I have received or am taking a treatment that targets B cells.
- I am able and willing to attend follow-up reviews over an extended period.
What does participation involve?
Taking part in this study focuses on long-term health tracking rather than testing a completely new, unproven drug. Because it is an observational follow-up study, you will continue your regular medical care while the team collects updates about your health.
You can expect occasional study visits, which may be scheduled alongside your usual hospital appointments. During these check-ups, the team may ask about your symptoms, review any new medications, and check for side effects. They may also arrange routine blood tests to look at your immune system and see how your B cells are recovering.
Some follow-ups might be done over the telephone or through secure online forms. The total time you spend in the study will usually span several months or years so doctors can build a complete picture of your health journey.
Potential risks and benefits
Locations (1)
- —UnverifiedGermany
Common questions
What are B cells?
B cells are a type of white blood cell that make antibodies to fight off bugs. In autoimmune diseases, they can mistakenly create antibodies that attack healthy parts of your own body.
Will I receive a new medicine in this study?
This is primarily a long-term follow-up study designed to monitor the effects of B-cell treatments you have already had or are receiving, rather than testing a brand-new drug.
How often will I need to visit the hospital?
Visits are usually spaced out over months or years. The researchers often try to arrange study check-ups at the same time as your routine clinic visits to save you travel.
Can I leave the study if I change my mind?
Yes. Taking part is completely voluntary. You can withdraw whenever you wish, and your usual medical care will continue as normal.
Does it cost anything to take part?
No, taking part is free. Many clinical trials also offer help with travel expenses for study-related visits.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.